Wiegers adopts a comprehensive approach, delving into the adequacy of process validations, the clarity of product acceptance status, and the definition of procedures for nonconforming products. He values strong organizational structures that support effective quality control. Furthermore, he rebukes any inadequacies in maintaining key regulatory documentation.

FDA investigator Daring Wiegers has shown a stringency towards regulatory and procedural shortcomings during his audits. His focus rests primarily on product quality, the validation of processes, regulatory documentation, and handling of non-conforming products. Wiegers does not shy away from acknowledging structural issues in an organization's quality control systems. His thoroughness reflects an auditor who values safety, quality, and comprehensive adherence to FDA regulations.